An Indian man who helped test a coronavirus jab based on AstraZeneca’s candidate vaccine has filed suit, claiming that he suffered extreme side effects during his participation in the trial. The plaintiff, identified in media reports as a 40-year-old man from Chennai, is suing the Pune-based Serum Institute of India (SII) for Rs 5 crore ($676,000 USD). The individual alleges that he suffered serious neurological damage after taking part in the phase three trial of Covishield, the SII’s version of the Covid-19 jab being developed by AstraZeneca and the University of Oxford. The man was purportedly told that the vaccine was safe and chos
Hence then, the article about participant in india s astrazeneca covid 19 vaccine trial sues after experiencing severe adverse effect was published today ( ) and is available onRussia Today ( News ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Participant in India’s AstraZeneca Covid-19 vaccine trial sues after experiencing ‘severe adverse effect’ )